Jason H Haga

Title: Jason H Haga: Innovator in Cancer Research and Cell Regulation

Introduction

Jason H Haga is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer research and cell regulation through his innovative work. His research focuses on the regulation of actin filaments, which play a crucial role in various cellular processes.

Latest Patents

Haga holds a patent for SSH-2 (slingshot-2) inhibitors and methods for making and using them. This invention provides compositions that inhibit the polypeptide SSH-2, a phosphatase enzyme that regulates actin filaments. The methods described in the patent include administering these compositions to regulate or modify actin filament polymerization by inhibiting SSH-2. In one embodiment, the compositions slow or inhibit F-actin depolymerization and severing. Additionally, the invention has potential applications in slowing or inhibiting cell motility, as well as addressing the progression of cancer, metastasis, and Alzheimer's disease.

Career Highlights

Haga is affiliated with the University of California, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on understanding and treating various diseases.

Collaborations

Haga collaborates with notable colleagues, including Phillip D Pham and Marshall J Levesque. Their combined expertise contributes to the advancement of research in cell regulation and cancer treatment.

Conclusion

Jason H Haga is a dedicated inventor whose work in SSH-2 inhibitors represents a significant advancement in cancer research and cell regulation. His contributions have the potential to influence future therapeutic strategies for various diseases.